Why did CANF (CANF) stock rise Wednesday?
· The positive clinical study news today has CANF stock seeing heavier-than-normal trading. That includes some 128 million shares of the stock changing hands. This is a massive jump over its daily ...
How did CANF stock react to positive clinical study news?
· Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CANF. News Sentiment. .
Is Can-Fite BioPharma Ltd’s stock oversold or overbought?
· Real-time trade and investing ideas on Can-Fite BioPharma Ltd. CANF from the largest community of traders and investors. Rooms Shows Rankings Earnings Newsletters Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Can-Fite BioPharma Ltd. 0.84 0.00 (0.01%) Watch.
Why did korsuva stock drop so much today?
· Shares of CANF stock opened higher by 16.7% on Wednesday after the company reported positive results from a Phase 2 clinical trial for …
Can you fight Biopharma?
is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The Company has an advanced pipeline of proprietary drug candidates in Phase II and Phase III clinical development which address inflammatory, liver and metabolic diseases.
Will CANF stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Can Fite Biopharma Ltd have a median target of 5.50, with a high estimate of 8.25 and a low estimate of 5.00. The median estimate represents a +433.98% increase from the last price of 1.03.
Is CANF stock a good buy?
The financial health and growth prospects of CANF, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.
Can CNN Money forecast?
Canaan Inc (NASDAQ:CAN) The 1 analysts offering 12-month price forecasts for Canaan Inc have a median target of 14.17, with a high estimate of 14.17 and a low estimate of 14.17. The median estimate represents a +393.87% increase from the last price of 2.87.
Why is OCGN stock down?
Now, shares of OCGN stock are down roughly 20% today after negative news from the U.S. Food and Drug Administration (FDA). Specifically, Ocugen announced this morning that the FDA has declined its pediatric Emergency Use Authorization (EUA) application for Covaxin, the company's vaccine candidate for Covid-19.
The company announced disappointing results from two clinical studies
Key Points
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
What happened
Allokos said that lirentelimab failed to meet co-primary endpoints in two clinical studies.
So what
Shares of Allakos ( NASDAQ:ALLK) are crashing 88% lower as of 10:17 a.m ET on Wednesday. The huge decline came after the company announced results from its phase 3 Enigma 2 and its phase 2/3 Kryptos clinical studies evaluating lirentelimab.
Now what
The biotech stock plunged so much because the co-primary endpoint misses weren't even close. That's especially problematic because lirentelimab is Allokos' only pipeline candidate in clinical development.
What happened
Paterson stated that Allokos "at present" plans to continue analyzing the data from the two studies in an effort to determine a path forward for lirentelimab in treating eosinophilic gastrointestinal diseases.
So what
Shares of Cara Therapeutics ( CARA 0.20% ) were crashing 43.9% lower as of 11:17 a.m. EDT on Thursday. The big drop came after the company announced results from its phase 2 study evaluating oral Korsuva in treating moderate-to-severe pruritis in patients with atopic dermatitis.
Now what
With the biotech stock falling so heavily today, you'd think that all the results from the phase 2 trial were really bad. That wasn't entirely the case, though.
Why was Johnny Depp imprisoned?
Despite the bad news, Cara Therapeutics doesn't think it's the end of the road for oral Korsuva in treating atopic dermatitis. Chief Medical Officer Joana Goncalves said, "We now have a defined patient group and active dose range for Oral KORUSVA in which to design a registration program that we expect to discuss with the FDA in the coming months."
Why did Johnny Depp sue Heard?
In November 2016, Depp joined the campaign Imprisoned for Art to call for the release of Ukrainian filmmaker Oleg Sentsov, who was being held in custody in Russia.